Adamas Pharma (ADMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADMS | ASMB | SLGL | ||
| Company | Adamas Pharma | Assembly Biosciences | Sol-Gel Technologies Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 8.24 | 30.08 | 83.69 | ||
| High | 8.25 | 33.17 | 90.79 | ||
| Low | 8.18 | 29.78 | 83.69 | ||
| Last | 8.22 | 32.95 | 84.69 | ||
| Change | +0.06 | +3.00 | +0.65 | ||
| Percent Change | +0.74% | +10.02% | +0.77% | ||
| Volume | 3,151,400 | 559,100 | 79,400 | ||
| 20-Day Average Volume | 834,440 | 174,985 | 58,735 | ||
| Previous | 8.16 | 29.95 | 84.04 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 8.16 | 26.58 | 83.09 | ||
| 20-Day Raw Stochastic | 86.36% | 97.52% | 60.53% | ||
| 20-Day Relative Strength | 73.46 | 69.71 | 53.80 | ||
| Weighted Alpha | +22.54 | +27.22 | +203.32 | ||
| Today's Opinion | 100% Buy | 8% Buy | 88% Buy | ||
| Yesterday's Opinion | 96% Buy | 8% Buy | 88% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Sell | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.86% since 11/16/21 | +23.50% since 08/07/26 | -3.76% since 08/07/26 | ||
| Low | 8.15 on 11/17/21 | 26.24 on 08/11/26 | 70.81 on 08/12/26 | ||
| High | 8.25 on 11/23/21 | 33.17 on 08/14/26 | 90.79 on 08/14/26 | ||
| 1-Month | |||||
| %Chg | +2.62% since 10/22/21 | +23.13% since 07/14/26 | +12.34% since 07/14/26 | ||
| Low | 8.00 on 10/25/21 | 24.50 on 07/29/26 | 70.81 on 08/12/26 | ||
| High | 8.25 on 11/23/21 | 33.17 on 08/14/26 | 93.74 on 07/22/26 | ||
| 3-Month | |||||
| %Chg | +77.54% since 08/23/21 | +8.75% since 05/14/26 | +23.31% since 05/14/26 | ||
| Low | 4.41 on 08/27/21 | 21.80 on 06/11/26 | 62.50 on 05/19/26 | ||
| High | 8.25 on 11/23/21 | 33.17 on 08/14/26 | 93.74 on 07/22/26 | ||
| 6-Month | |||||
| %Chg | +57.47% since 05/21/21 | +23.59% since 02/13/26 | +26.03% since 02/13/26 | ||
| Low | 4.02 on 08/16/21 | 21.80 on 06/11/26 | 61.92 on 03/23/26 | ||
| High | 8.25 on 11/23/21 | 33.17 on 08/14/26 | 97.97 on 03/03/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 376,369 | 523,674 | 237,970 | ||
| Shares Outstanding, K | 45,787 | 15,893 | 2,810 | ||
| Annual Sales, $M | 74,460,000 | 72,300,000 | 19,390,000 | ||
| Annual Net Income, $M | -57,400,000 | -6,120,000 | -6,130,000 | ||
| Last Qtr Sales, $M | 25,900,000 | 8,210,000 | 110,000 | ||
| Last Qtr Income, $M | -19,520,000 | -9,080,000 | -3,730,000 | ||
| 60-Month Beta | 2.82 | 1.10 | 1.12 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/10/21 | -0.54 on 05/07/26 | -1.31 on 05/28/26 | ||
| Latest Earnings Date | 02/22/22 | 11/09/26 | 08/21/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 29.36 | 0.00 | ||